FindTrial
Sign In

How long is caffeine duration enough for preterm infants?

Effect of short course caffeine on recurrence of apnea of prematurity in preterm infants =32 weeks- A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036141
Enrollment
174
Registered
2021-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P073- Preterm [premature] newborn [other]

Interventions

Intervention1: Short course caffeine therapy: stopping caffeine therapy after a 7 day apnea freaa or 7 day respiratory support free period Control Intervention1: Regular course caffeine therapy: conti

Sponsors

Chengalpattu government medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All preterm neonates with birth gestation 26-32 weeks and on caffeine therapy

Exclusion criteria

Exclusion criteria: 1.Major congenital anamolies 2.Grade 3 or 4 Intraventricular hemorrhage. 3.Post hemorrhagic hydrocephalus.

Design outcomes

Primary

MeasureTime frame
Incidence of recurrence of apnea of prematurity.Timepoint: within 7 days after stopping caffeine therapy—

Secondary

MeasureTime frame
Incidence of Adverse effectsTimepoint: During hospital stay;Incidence of Brochopulmonary dysplasia.Timepoint: At the time of discharge;Incidence of Extrauterine growth restriction.Timepoint: AT hospital stay;Neurodevelopmental outcome.Timepoint: At, one year follow up.—

Countries

India

Contacts

Public ContactPradhap K

Chengalpattu Government Medical College

pradhapkrish@gmail.com9524187793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026